Back to Results
First PageMeta Content
Food and Drug Administration / Anorectics / Pharmaceutical industry / Mood stabilizers / Teratogens / Sibutramine / Orlistat / Valproic acid / MedWatch / Medicine / Pharmacology / Chemistry


FDA Patient Safety News: Show #96, March 2010
Add to Reading List

Open Document

File Size: 33,46 KB

Share Result on Facebook

Company

Encompass Group / The Medicines Company / Cleviprex / Nipro Medical Corporation / Exel International Corporation / Nipro Medical Corporation for Exel International / /

Event

Product Issues / FDA Phase / Product Recall / /

IndustryTerm

inert stainless steel particles / needle manufacturer / Sexual enhancement products / healthcare practitioners / healthcare professionals / prescription products / needle products / counterfeit product / healthcare professional / /

MedicalCondition

inflammatory reactions / neural tube defects / nausea / heart disease / injury / end-stage renal disease / birth defects / pre-existing kidney disease / insomnia / flushing / migraines / erectile dysfunction / hypothermia / dull ache / diabetes / erythema / lethargy / high cholesterol / vomiting / renal insufficiency / migraine headaches / dangerously low blood pressure / epilepsy / high blood pressure / Renal Failure / Acute renal failure / bipolar disorder / dehydration / /

MedicalTreatment

dietary supplements / contraception / alternative therapies / /

Organization

Institute for Safe Medication Practices / FDA / FDA's office of Criminal Investigations / /

Person

Huber Safety Sets Affected / Huber Needles / /

/

Position

physician / wholesaler / /

Product

Safe Medication / Byetta / blood / divalproex sodium / Cleviprex injectable emulsion / Valproate Sodium / Levitra / nitroglycerin / products / Depakene / Depacon / folic acid / valproic acid / Cialis / Viagra / ISMP Medication / Alli / Depakote / sildenafil citrate / /

Technology

MRI / /

URL

http /

SocialTag